Efficacy and Safety of NP-2007 on Skin Health

A 12-week, Randomized, Double-Blind, Placebo-Controlled Human Clinical Study to Evaluate the Efficacy and Safety of Small-Molecular-Weight Deer Antler Collagen (NP-2007) for Improving Skin Health

NCT07486414•Hanpoong Nature Pharm Co., Ltd.

View on ClinicalTrials.gov

Summary

The objective of this study is to evaluate the efficacy and safety of Small-molecular-weight deer antler collagen (NP-2007) on skin health, including skin hydration, transepidermal water loss (TEWL), elasticity, and eye wrinkles.

Eligibility

Age

35 - 65 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•1. Healthy females between 35 and 65 years of age
•2. Subjects with dry skin (Skin capacitance ≤ 49 units measured by Corneometer® CM 825)
•3. Subjects with eye wrinkles (grade 3 or higher based on visual assessment scale)
•4. Subjects who voluntarily signed the informed consent form after receiving a full explanation of the study
•5. Subjects who are available for follow-up visits at scheduled times throughout the study period

Exclusion Criteria

•1\) Subjects with skin diseases (atopic dermatitis, psoriasis, etc.) in the test area
•2\) Subjects who have used skin-related medications (steroids, etc.) within 1 month
•3\) Subjects with a history of hypersensitivity to the test ingredients or severe food allergies
•4\) Pregnant or lactating women, or those planning to become pregnant
•5\) Subjects who have participated in other clinical trials within the past 3 months
•6\) Any other conditions that the investigator deems unsuitable for participation

Locations (1)

Corederm Skin Research Center

Seoul, South Korea

Key Dates

Start Date

April 4, 2022

Primary Completion Date

July 15, 2022

Completion Date

September 30, 2022

Last Updated

March 20, 2026

Enrollment

ACTUAL participants

Conditions

Skin Aging, Dry Skin

Interventions

NP-2007

DIETARY_SUPPLEMENT

Placebo

DIETARY_SUPPLEMENT